1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1484 participants.

Also called NCT07592507

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,484 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07592507
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07592507. Randomized; single masking; primary purpose treatment. Start 2026-05 (anticipated); primary completion 2032-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease
Acronym
D-ONE
Condition
Stable Angina Pectoris
Intervention (Drug)
1-Month DAPT followed by SAPT
Intervention (Drug)
6-Month DAPT followed by SAPT
Lead sponsor
Daejeon St. Mary's hospital (class: other)

Record details

Record id
cardio:ct-nct07592507
Content hash
8b35db6f52143957e26bb84bfdde58c4ffbe1d317c428d060c4777a4bda55513